Antimicrobial resistance and its impact on cancer care

Antimicrobial resistance (AMR) or drug resistance, including antibiotic resistance, is a growing public health issue and needs urgent attention in countries around the world. Due to a variety of factors, people with cancer are particularly vulnerable to AMR, which is threatening the progress being made in cancer care.

Antimicrobial Resistance Death Toll Could Catch Up To Cancer By 2050, And Pollution Is Fuelling Its Spread - Health Policy Watch

Antibiotic Resistance Calls Future of Cancer Treatment Into Question

A global baseline for qPCR-determined antimicrobial resistance gene prevalence across environments - ScienceDirect

Baxter Italia on LinkedIn: #hemovision #hemovision #hpbsurgery #webinar #hpb…

Pan-Canadian Action Plan on Antimicrobial Resistance

Antimicrobial resistance and its impact on cancer care

Baxter Italia su LinkedIn: #hemovision #neurochirurgia #savingandsustaininglives

What is antimicrobial resistance and why do we need to take action against it? – UK Health Security Agency

Antimicrobial therapy during cancer treatment: Beyond antibacterial effects - Ghanem - 2021 - Journal of Internal Medicine - Wiley Online Library

The impact of antibiotic resistance on cancer treatment, especially in low-and middle-income countries, and the way forward – 2022 – ReAct

Water, Free Full-Text

Cancer Drug Resistance

Master course: Antimicrobial resistance and its impact on cancer care, UICC